These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15377055)

  • 1. Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome.
    Santaella ML; Font I; Disdier OM
    P R Health Sci J; 2004 Jun; 23(2):89-93. PubMed ID: 15377055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome.
    Forsyth LM; Preuss HG; MacDowell AL; Chiazze L; Birkmayer GD; Bellanti JA
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):185-91. PubMed ID: 10071523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome].
    Alegre J; Rosés JM; Javierre C; Ruiz-Baqués A; Segundo MJ; de Sevilla TF
    Rev Clin Esp; 2010 Jun; 210(6):284-8. PubMed ID: 20447621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
    Amsterdam JD; Shults J; Rutherford N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):100-6. PubMed ID: 17804135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial.
    Castro-Marrero J; Sáez-Francàs N; Segundo MJ; Calvo N; Faro M; Aliste L; Fernández de Sevilla T; Alegre J
    Clin Nutr; 2016 Aug; 35(4):826-34. PubMed ID: 26212172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome.
    McDermott C; Richards SC; Thomas PW; Montgomery J; Lewith G
    QJM; 2006 Jul; 99(7):461-8. PubMed ID: 16809351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of the dehydroepiandrosterone-annexed vitamin C infusion treatment in the clinical control of chronic fatigue syndrome (CFS). II. Characterization of CFS patients with special reference to their response to a new vitamin C infusion treatment.
    Kodama M; Kodama T; Murakami M
    In Vivo; 1996; 10(6):585-96. PubMed ID: 8986468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The assessment of the energy metabolism in patients with chronic fatigue syndrome by serum fluorescence emission.
    Mikirova N; Casciari J; Hunninghake R
    Altern Ther Health Med; 2012; 18(1):36-40. PubMed ID: 22516851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome.
    Kop WJ; Lyden A; Berlin AA; Ambrose K; Olsen C; Gracely RH; Williams DA; Clauw DJ
    Arthritis Rheum; 2005 Jan; 52(1):296-303. PubMed ID: 15641057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is cognitive behaviour therapy for chronic fatigue syndrome also effective for pain symptoms?
    Knoop H; Stulemeijer M; Prins JB; van der Meer JW; Bleijenberg G
    Behav Res Ther; 2007 Sep; 45(9):2034-43. PubMed ID: 17451642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M
    Arch Gerontol Geriatr; 2008; 46(2):181-90. PubMed ID: 17658628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cognitive function and psychological characteristics of patients with chronic fatigue syndrome].
    Li YJ; Gao XG; Wang DX; Lin T; Bai XL; Yang FZ
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(41):2926-9. PubMed ID: 16324367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
    Castro-Marrero J; Segundo MJ; Lacasa M; Martinez-Martinez A; Sentañes RS; Alegre-Martin J
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?
    Castro-Marrero J; Cordero MD; Segundo MJ; Sáez-Francàs N; Calvo N; Román-Malo L; Aliste L; Fernández de Sevilla T; Alegre J
    Antioxid Redox Signal; 2015 Mar; 22(8):679-85. PubMed ID: 25386668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
    Blockmans D; Persoons P; Van Houdenhove B; Bobbaers H
    Am J Med; 2006 Feb; 119(2):167.e23-30. PubMed ID: 16443425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cognitive behavioral therapy for adolescents with chronic fatigue syndrome: long-term follow-up of a randomized, controlled trial.
    Knoop H; Stulemeijer M; de Jong LW; Fiselier TJ; Bleijenberg G
    Pediatrics; 2008 Mar; 121(3):e619-25. PubMed ID: 18310181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of patients with chronic fatigue syndrome: analysis of 82 cases].
    Li YJ; Wang DX; Bai XL; Chen J; Liu ZD; Feng ZJ; Zhao YM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):701-4. PubMed ID: 15932738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms.
    Shoemaker RC; House DE
    Neurotoxicol Teratol; 2006; 28(5):573-88. PubMed ID: 17010568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.